HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nagahiko Sakuma Selected Research

Nagahiko Sakuma Research Topics

Disease

4Atherosclerosis
09/2018 - 01/2002
2Sitosterolemia
09/2018 - 12/2017
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2009 - 11/2003
1Xanthomatosis (Xanthoma)
09/2018
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2014
1Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2014
1Cardiovascular Diseases (Cardiovascular Disease)
06/2009
1Hypercholesterolemia
06/2009
1Alcoholic Cardiomyopathy
01/2008
1Hypertriglyceridemia
11/2003

Drug/Important Bio-Agent (IBA)

3oxidized low density lipoproteinIBA
09/2018 - 08/2002
2LDL CholesterolIBA
09/2018 - 01/2002
2CholesterolIBA
11/2003 - 01/2002
1Phytosterols (Plant Sterols)IBA
09/2018
1colestimideIBA
09/2018
1Ezetimibe (Zetia)FDA Link
09/2018
1Proprotein Convertase 9IBA
09/2018
1gamma-sitosterol (beta-sitosterol)IBA
09/2018
1PCSK9 InhibitorsIBA
09/2018
1Lipoproteins (Lipoprotein)IBA
12/2017
1Arginine (L-Arginine)FDA Link
01/2014
1Apolipoproteins E (ApoE)IBA
01/2014
1Amino AcidsFDA Link
01/2014
1LDL Receptors (LDL Receptor)IBA
01/2014
1apolipoprotein E1IBA
01/2014
1Apolipoprotein E2IBA
01/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2009
1AcetaldehydeIBA
01/2008
1HDL CholesterolIBA
11/2003
1Triglycerides (Triacylglycerol)IBA
11/2003
1BezafibrateIBA
11/2003
1HDL2 LipoproteinsIBA
11/2003
1LipidsIBA
01/2002

Therapy/Procedure

2Blood Component Removal (Apheresis)
09/2018 - 12/2017
1Therapeutics
09/2018
1Percutaneous Coronary Intervention
06/2009